Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Activity of DNA-targeted C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates against aerobically and hypoxically grown Mycobacterium tuberculosis under acidic and neutral conditions.

Iacobino A, Giannoni F, Fattorini L, Brucoli F.

J Antibiot (Tokyo). 2018 Sep;71(9):831-834. doi: 10.1038/s41429-018-0068-5. Epub 2018 May 24.

PMID:
29795520
2.

Trend in rifampicin-, multidrug- and extensively drug-resistant tuberculosis in Italy, 2009-2016.

Mustazzolu A, Borroni E, Cirillo DM, Giannoni F, Iacobino A; Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA), Fattorini L.

Eur Respir J. 2018 Jul 19;52(1). pii: 1800070. doi: 10.1183/13993003.00070-2018. Print 2018 Jul. No abstract available.

PMID:
29724919
3.

Improved Bactec MGIT 960 Pyrazinamide Test Decreases Detection of False Mycobacterium tuberculosis Pyrazinamide Resistance.

Mustazzolu A, Iacobino A, Giannoni F, Piersimoni C; Italian Multicentre Study on Resistance to Antituberculosis Drugs (SMIRA) Group, Fattorini L.

J Clin Microbiol. 2017 Dec;55(12):3552-3553. doi: 10.1128/JCM.01437-17. Epub 2017 Sep 13. No abstract available.

4.

Fighting tuberculosis by drugs targeting nonreplicating Mycobacterium tuberculosis bacilli.

Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L.

Int J Mycobacteriol. 2017 Jul-Sep;6(3):213-221. doi: 10.4103/ijmy.ijmy_85_17. Review.

5.

Galleria mellonella as an in vivo model for assessing the protective activity of probiotics against gastrointestinal bacterial pathogens.

Scalfaro C, Iacobino A, Nardis C, Franciosa G.

FEMS Microbiol Lett. 2017 Apr 1;364(7). doi: 10.1093/femsle/fnx064.

PMID:
28369512
6.

Activity of drugs against dormant Mycobacterium tuberculosis.

Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L.

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S94-S95. doi: 10.1016/j.ijmyco.2016.09.061. Epub 2016 Nov 12.

7.

Drug-resistant tuberculosis in Naples, 2008-2013.

Del Giudice A, Mustazzolu A, Iacobino A, Perna R, Smeraglia R, Marino R, Fattorini L, Santoro G.

Ann Ist Super Sanita. 2016 Oct-Dec;52(4):603-607. doi: 10.4415/ANN_16_04_23.

8.

Mycobacterium tuberculosis Is Selectively Killed by Rifampin and Rifapentine in Hypoxia at Neutral pH.

Iacobino A, Piccaro G, Giannoni F, Mustazzolu A, Fattorini L.

Antimicrob Agents Chemother. 2017 Feb 23;61(3). pii: e02296-16. doi: 10.1128/AAC.02296-16. Print 2017 Mar.

9.

Pyrazinamide susceptibility testing: proposed new standard with the BACTECTM MGITTM 960 system.

Piersimoni C, Mustazzolu A, Iacobino A, Giannoni F, Santoro G, Gherardi G, Del Giudice A, Perna R, Fattorini L.

Int J Tuberc Lung Dis. 2016 Dec;20(12):1677-1680.

PMID:
27931346
10.

Effects of Megaplasmid Loss on Growth of Neurotoxigenic Clostridium butyricum Strains and Botulinum Neurotoxin Type E Expression.

Scalfaro C, Iacobino A, Grande L, Morabito S, Franciosa G.

Front Microbiol. 2016 Feb 25;7:217. doi: 10.3389/fmicb.2016.00217. eCollection 2016.

11.

Structure and genetic content of the megaplasmids of neurotoxigenic clostridium butyricum type E strains from Italy.

Iacobino A, Scalfaro C, Franciosa G.

PLoS One. 2013 Aug 15;8(8):e71324. doi: 10.1371/journal.pone.0071324. eCollection 2013.

12.

Stenotrophomonas maltophilia strains from cystic fibrosis patients: genomic variability and molecular characterization of some virulence determinants.

Nicoletti M, Iacobino A, Prosseda G, Fiscarelli E, Zarrilli R, De Carolis E, Petrucca A, Nencioni L, Colonna B, Casalino M.

Int J Med Microbiol. 2011 Jan;301(1):34-43. doi: 10.1016/j.ijmm.2010.07.003. Epub 2010 Oct 16.

PMID:
20952251
13.

Interference of the CadC regulator in the arginine-dependent acid resistance system of Shigella and enteroinvasive E. coli.

Casalino M, Prosseda G, Barbagallo M, Iacobino A, Ceccarini P, Latella MC, Nicoletti M, Colonna B.

Int J Med Microbiol. 2010 Jun;300(5):289-95. doi: 10.1016/j.ijmm.2009.10.008. Epub 2009 Dec 2.

PMID:
19959396

Supplemental Content

Loading ...
Support Center